Pharmacodynamic activity of the lantibiotic MU1140.
Pharmacodynamic activity of the lantibiotic MU1140.
复制标题
DOI:
10.1016/j.ijantimicag.2008.07.028
复制
发表时间:
2009-01
影响因子:
10.8
通讯作者:
Hillman, Jeffery D.
中科院分区:
文献类型:
--
作者:
Ghobrial, Oliver G.;Derendorf, Hartmut;Hillman, Jeffery D.
This study evaluated the pharmacodynamics of the lantibiotic MU1140 and the ability of selected organisms to develop resistance to this antibiotic. MU1140 demonstrated activity against all Gram-positive organisms tested, including oxacillin- and vancomycin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis (VREF). No activity was observed against Gram-negative bacteria or yeast. Time–kill studies revealed that MU1140 was rapidly bactericidal against Streptococcus pneumoniae and multidrug-resistant S. aureus, whilst it was bacteriostatic against VREF. In vitro resistance development to MU1140, tested by sequential subculturing in subinhibitory concentrations of MU1140, revealed a stable three-fold increase in the minimum inhibitory concentration (MIC) for S. aureus and S. pneumoniae. Subsequent subculturing of the strains with elevated MICs in antibiotic-free media for 7 days did not result in a reduction of their MIC values for MU1140. Collectively, our findings illustrate the therapeutic potential of MU1140 for management of Gram-positive infections.
登录
查看更多内容
影响因子:
3.1
作者:
HILLMAN, JD;JOHNSON, KP;YAPHE, BI
通讯作者:
YAPHE, BI
影响因子:
4.9
作者:
BAILEY, EM;RYBAK, MJ;KAATZ, GW
通讯作者:
KAATZ, GW
影响因子:
2.9
作者:
Smith, Leif;Hasper, Hester;Orugunty, Ravi S.
通讯作者:
Orugunty, Ravi S.
DOI:
10.1179/096805105x37394
发表时间:
2005-01-01
期刊:
JOURNAL OF ENDOTOXIN RESEARCH
影响因子:
--
作者:
Bowdish, DME;Hancock, REW
通讯作者:
Hancock, REW
影响因子:
56.9
作者:
Hasper, Hester E.;Kramer, Naomi E.;Breukink, Eefjan
通讯作者:
Breukink, Eefjan